Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology

May 2nd, 2023 - VANCOUVER, BRITISH COLUMBIA Albert Labs International Corp. (CSE: ABRT) (the "Company" or "Albert Labs"), a fully-integrated biopharmaceutical drug discovery company bringing innovative medicines to patients with unmet…

Continue ReadingAlbert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology

Albert Labs Announces Private Placement

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs Announces Private Placement

Letter of Intent (LOI) for First-In-Human studies with iNGENū CRO

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingLetter of Intent (LOI) for First-In-Human studies with iNGENū CRO

Albert Labs Provides Corporate Update

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs Provides Corporate Update

New International PCT Patent Application for scalable API manufacturing

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingNew International PCT Patent Application for scalable API manufacturing

Albert Labs Appoints Two Industry Leading Directors

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs Appoints Two Industry Leading Directors

Albert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101